Plain-English translation of NCT05598632 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This is a large research study that will follow about 27,000 patients in China who have atrial fibrillation—an irregular heartbeat condition. Researchers will collect information about your health, medical history, treatments, and blood tests over approximately 3 years to identify which factors make some patients more likely to have a stroke or blood clot. By understanding these patterns, doctors hope to better predict and prevent these serious complications in future patients.
Atrial fibrillation puts patients at higher risk for stroke, but doctors don't fully understand which patients are at greatest risk or how to best protect them. This study aims to identify the specific warning signs and risk factors so treatment can be more personalized and effective.
You likely qualify if…
You likely don't qualify if…
You will visit a hospital or clinic to provide your medical information, answer questions about your health history, and have blood drawn for testing. Your doctors will also share your medical records, heart imaging results, and other test results with the research team. Over the next 3 years, the research center will monitor your health to track any stroke, blood clots, heart problems, or hospitalizations you may experience, helping researchers understand what factors predict these events.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China
Sponsor
China National Center for Cardiovascular Diseases
Enrollment target
~22,000 participants
Started
April 2023
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 120 Years
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Zhe Zheng, MD, PhD
Fuwai Hospital, Chinese Academy of Medical Science
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.